Ledger.Open graph →
SEC Form D · filed August 17, 2021

ADARx Pharmaceuticals, Inc

Offering
$75.0M
Sold
$75.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

James D. Rippeto, Jr · Houston, TXExec · DirectorRuwack Trust · GREENSBORO, NCExecPaul Song · Los Angeles, CADirectorSheila Gujrathi · San Diego, CADirectorCarl Gordon · San Diego, CADirectorYuan Sun · San Diego, CADirectorSimeon George · Cambridge, MADirectorErez Chimovits · San Diego, CADirectorCharles Reim · San Francisco, CADirectorXiong Zhang · San Diego, CADirectorEdward Chen · Los Altos, CADirectorZhen Li · San Diego, CAExec · DirectorRui Zhu · San Diego, CAExecRoger A. Mills · Philadelphia, PADirectorAlex C. Sun · Whittier, CADirectorKevin E. Marchetti · Novi, MIDirectorJeffrey Takimoto · Los Angeles, CADirectorYuan Sun · San Diego, CADirectorSimeon George · Menlo Park, CADirectorDaryl Brooks · Grandview, TXExec · DirectorGurwinder Singh · Jericho, NYExecCary Marr · GEORGE TOWN GRAND CAYMAN, Cayman IslandsDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗